Literature DB >> 1764779

Serum catalase: reversibly formed charge isoform of erythrocyte catalase.

L Góth1.   

Abstract

The different electrophoretic mobilities of erythrocyte and serum catalase (EC 1.11.1.6) were confirmed and the causes responsible for their differences were examined. The presence of a catalase-binding protein in serum that could form a complex with erythrocyte catalase was excluded by incubating serum proteins with erythrocyte catalase. No new unequivocal catalase bands representing a catalase-binding protein were detected. The erythrocyte and serum catalase proved to be charge isoforms: their molecular masses, estimated by gel permeation chromatography or polyacrylamide gel electrophoresis in a nondenaturing system, were very similar, whereas their electrophoretic mobilities were different. Assay of serum catalase by gel permeation and hydrophobic chromatography yielded a product with the same electrophoretic mobility as that of erythrocyte catalase. Different dilution of erythrocyte catalase with human sera led to a gradual decrease of its mobility, 20-fold or greater dilution yielding the same results as for serum catalase. Similarly, when serum catalase was diluted 20-fold or more with 60 mmol/L phosphate buffer, it migrated similarly to erythrocyte catalase. I detected no effect of dialyzable serum ligands, NADPH, or protection of SH groups on the electrophoretic mobility of either catalase isoform. I conclude that formation of charge isoforms of catalase is caused by a reversible, conformational modification due to matrix effect of serum.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1764779

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  6 in total

1.  Cerebrospinal fluid and plasma oxidative stress biomarkers in different clinical phenotypes of neuroinflammatory acute attacks. Conceptual accession: from fundamental to clinic.

Authors:  Srdjan Ljubisavljevic; Ivana Stojanovic; Slobodan Vojinovic; Dragan Stojanov; Svetlana Stojanovic; Gordana Kocic; Dejan Savic; Tatjana Cvetkovic; Dusica Pavlovic
Journal:  Cell Mol Neurobiol       Date:  2013-05-16       Impact factor: 5.046

2.  A novel mechanism of vitamin D anti-inflammatory/antioxidative potential in type 2 diabetic patients on metformin therapy.

Authors:  Milena Cojic; Radivoj Kocic; Aleksandra Klisic; Ljiljana Cvejanov-Kezunovic; Nebojsa Kavaric; Gordana Kocic
Journal:  Arch Med Sci       Date:  2020-02-04       Impact factor: 3.318

3.  Gender differences in oxidative and nitrosative stress parameters in kidney transplant patients on tacrolimus-based immunosuppression.

Authors:  Tatjana P Cvetkovic; Nikola Z Stefanovic; Radmila M Velickovic-Radovanovic; Goran J Paunovic; Vidojko M Djordjevic; Dijana R Stojanovic; Ivana R Stojanovic; Dusica D Pavlovic
Journal:  Int Urol Nephrol       Date:  2013-10-08       Impact factor: 2.370

4.  Oxidative and Nitrosative Stress in Stable Renal Transplant Recipients with Respect to the Immunosuppression Protocol - Differences or Similarities?

Authors:  Tatjana Cvetković; Radmila Veličković-Radovanović; Dijana Stojanović; Nikola Stefanović; Aleksandra Ignjatović; Ivana Stojanović; Nikola Sladojević; Dušica Pavlović
Journal:  J Med Biochem       Date:  2015-07-14       Impact factor: 3.402

5.  Finasteride Has Regionally Different Effects on Brain Oxidative Stress and Acetylcholinesterase Activity in Acute Thioacetamide-Induced Hepatic Encephalopathy in Rats.

Authors:  Dušan Mladenović; Nataša Petronijević; Tihomir Stojković; Milica Velimirović; Gordana Jevtić; Dragan Hrnčić; Tatjana Radosavljević; Aleksandra Rašić-Marković; Nebojša Maksić; Dragan Djuric; Olivera Stanojlović
Journal:  PLoS One       Date:  2015-08-04       Impact factor: 3.240

6.  Antioxidant property of Plantago major leaf extracts reduces testicular torsion/detorsion-induced ischemia/reperfusion injury in rats.

Authors:  Masoumeh Moradi-Ozarlou; Sara Javanmardi; Hossein Tayefi-Nasrabadi
Journal:  Vet Res Forum       Date:  2020-03-15       Impact factor: 1.054

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.